Traversa Therapeutics, Inc. and Sanofi-Aventis K.K. Enter into a Research Agreement for the Development of Traversa's RNAi Delivery Technology
3/25/2010 10:30:31 AM
More...
|
Company Profile for Traversa Therapeutics, Inc.
1/8/2010 9:37:42 AM
More...
|
Traversa Therapeutics, Inc. Appoints Curt W. Bradshaw, Ph.D. as VP of Research & Development
1/6/2010 12:04:58 PM
More...
|
Traversa Therapeutics, Inc. Completes Series B Financing; Raises $5 Million
4/2/2009 10:54:50 AM
More...
|
Traversa Therapeutics, Inc. Announces Appointment of William G. Kaelin, Jr., M.D. and Yitzhak Tor, Ph.D. to the Company’s Scientific Advisory Board
3/24/2009 11:49:43 AM
More...
|
Traversa Therapeutics, Inc. Announces Appointment of Barry Toyonaga Ph.D. as Senior Vice President, Business Development
4/21/2008 3:06:08 PM
More...
|
Company Profile for Traversa Therapeutics, Inc.
4/17/2008 3:20:24 PM
More...
|
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
2/4/2008 9:19:39 AM
More...
|